Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hendrik Gassmann

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancers|January 8, 2023
Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and OsteosarcomaValentina Evdokimova, Hendrik Gassmann, Laszlo Radvanyi, et al.
Frontiers in Oncology|February 15, 2024
YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cellsAnna Josefine von Ofen, Uwe Thiel, Jennifer Eck, et al.
Cells|November 27, 2021
Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell CytotoxicityEmilie Biele, Sebastian J Schober, Carolin Prexler, et al.
Cancers|November 26, 2022
T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive TransferBusheng Xue, Kristina von Heyking, Hendrik Gassmann, et al.
Frontiers in Immunology|February 6, 2024
TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse modelSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Cells|July 3, 2020
MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In VivoSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Frontiers in Immunology|December 26, 2024
Cytokine screening identifies TNF to potentially enhance immunogenicity of pediatric sarcomasHendrik Gassmann, Melanie Thiede, Jennifer Weiß, et al.
Cells|August 27, 2021
Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and FunctionHendrik Gassmann, Kira Schneider, Valentina Evdokimova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2023
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing SarcomaSebastian Johannes Schober, Caroline Schoening, Jennifer Eck, et al.
Frontiers in Oncology|May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care TherapySebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|January 8, 2023
Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and OsteosarcomaValentina Evdokimova, Hendrik Gassmann, Laszlo Radvanyi, et al.
Frontiers in Oncology|February 15, 2024
YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cellsAnna Josefine von Ofen, Uwe Thiel, Jennifer Eck, et al.
Cells|November 27, 2021
Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell CytotoxicityEmilie Biele, Sebastian J Schober, Carolin Prexler, et al.
Cancers|November 26, 2022
T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive TransferBusheng Xue, Kristina von Heyking, Hendrik Gassmann, et al.
Frontiers in Immunology|February 6, 2024
TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse modelSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Cells|July 3, 2020
MHC Class I-Restricted TCR-Transgenic CD4<sup>+</sup> T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In VivoSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Frontiers in Immunology|December 26, 2024
Cytokine screening identifies TNF to potentially enhance immunogenicity of pediatric sarcomasHendrik Gassmann, Melanie Thiede, Jennifer Weiß, et al.
Cells|August 27, 2021
Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and FunctionHendrik Gassmann, Kira Schneider, Valentina Evdokimova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2023
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing SarcomaSebastian Johannes Schober, Caroline Schoening, Jennifer Eck, et al.
Frontiers in Oncology|May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care TherapySebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.
Pageof 2